Skip to main content

Day: February 24, 2022

Osisko Development Reports Fourth Quarter 2021 and Year-End Results

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES MONTREAL, Feb. 24, 2022 (GLOBE NEWSWIRE) — Osisko Development Corp. (“Osisko Development” or the “Company“) (ODV: TSX-V) is pleased to report its financial and operating results for the three months ended December 31, 2021. Fourth Quarter and Full Year 2021 HighlightsThe Company began test mining and gold production from the Bonanza Ledge phase 2 mine and the San Antonio Stockpile heap leach mine.The Company recently entered into an agreement to acquire the high grade Trixie gold mine and prolific East Tintic mining district in Utah. The Trixie project is anticipated to add meaningful low-cost production to Osisko Development with expected low capital intensity.The Company advanced permitting on both its Cariboo...

Continue reading

Operational Highlights and Financial Results for the Period Ended December 31, 2021

Mesoblast Prepares for Resubmission of Biologics License ApplicationLate-Stage Clinical Pipeline Late-Stage Clinical PipelineNEW YORK, Feb. 24, 2022 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today reported financial results and operational highlights for the period ended December 31, 2021. Financial HighlightsMesoblast completed a refinancing of its senior secured debt facility with a new US$90 million five-year facility provided by funds managed by Oaktree Capital Management, L.P.Cash on hand at the end of the quarter was US$94.8 million, with up to an additional US$40 million available to be drawn down from existing financing facilities subject to certain milestones Total Operating Activities saw a 40% reduction in net cash usage...

Continue reading

Extendicare Announces 2021 Fourth Quarter and Year End Results

MARKHAM, Ontario, Feb. 24, 2022 (GLOBE NEWSWIRE) — Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) today reported results for the three and twelve months ended December 31, 2021. Results are presented in Canadian dollars unless otherwise noted. Fourth Quarter HighlightsOccupancy levels continued to recover in Q4 2021, with overall average occupancy up 110 bps in long-term care (“LTC”) and 210 bps in retirement communities Home health care average daily volume growth of 1.8% vs. Q3 2021 and 7.7% vs. Q4 2020 Commenced construction on Extendicare’s new 256-bed LTC home in Stittsville, our third LTC project under construction in Ontario High vaccination rates among our residents and our mandatory staff vaccination policy helped to mitigate serious illness and hospitalizations despite Omicron related outbreaks Subsequent...

Continue reading

Eldorado Gold Reports Strong 2021 Year-End and Fourth Quarter Financial and Operational Results; Meets 2021 Production and Cost Guidance; and Delivers on Key Organic Growth Projects

VANCOUVER, British Columbia, Feb. 24, 2022 (GLOBE NEWSWIRE) — Eldorado Gold Corporation, (“Eldorado” or “the Company”) today reports the Company’s financial and operational results for the fourth quarter and year ended December 31, 2021. For further information please see the Company’s Consolidated Financial Statements and Management’s Discussion and Analysis filed on SEDAR at www.sedar.com under the Company’s profile. Q4 2021 and Full-Year Highlights OperationsStrong gold production at the upper end of the increased guidance range: 122,582 ounces in Q4 2021, and 475,850 ounces in 2021, driven by Kisladag and Lamaque. Cash operating costs(1) within 2021 guidance range: $571 per ounce sold in Q4 2021, and $626 per ounce sold in 2021. A significant decrease in cash operating costs at Olympias in Q4 2021 was related to higher average...

Continue reading

EURO Ressources reports earnings for the year ended December 31, 2021

  NEWS RELEASE Paris: EUREURO RESSOURCES REPORTS EARNINGS FOR THE YEAR ENDED DECEMBER 31, 2021 Paris, France, February 24, 2022: EURO Ressources S.A. (“EURO” or “the Company”) (Paris: EUR) today announced its audited statutory financial results prepared in accordance with French Generally Accepted Accounting Principles (“GAAP”) and its audited financial results prepared in accordance with International Financial Reporting Standards (“IFRS”) for the year ended December 31, 2021. These audited financial results were approved by the Board of Directors on February 24, 2022. All financial amounts are expressed in Euros (“€” or “euros”) unless otherwise specified. Highlights Under French GAAP, EURO reported a net profit of €10.1 million (€0.162 per share) for the year ended December 31, 2021, compared to €10.8 million (€0.173 per...

Continue reading

Portage Biotech Announces Financial Results and Provides Business Update for Third Quarter of 2022 Fiscal Year

Company working to accelerate lead clinical programs; expects multiple clinical readouts in 2022 WESTPORT, Conn., Feb. 24, 2022 (GLOBE NEWSWIRE) — Portage Biotech Inc. (NASDAQ: PRTG) (“Portage” or the “Company”), a clinical-stage immuno-oncology company developing therapies to improve patient lives and increase survival by avoiding and overcoming cancer treatment resistance, today announced financial results for the quarter ended December 31, 2021 (the “third quarter”). “During the third quarter and in recent weeks we’ve taken steps to accelerate our lead programs for PORT-2 and PORT-3, investigating options to expand our clinical sites beyond our current footprint and finding the means of accelerating patient enrollment,” said Dr. Ian Walters, chief executive officer of Portage. “With our enhanced management team, efficient organization,...

Continue reading

Guardian Capital Group Limited (TSX: GCG; GCG.A) Announces Operating Results for Year Ended December 31, 2021

TORONTO, Feb. 24, 2022 (GLOBE NEWSWIRE) — All per share figures disclosed below are stated on a diluted basis.     For the twelve months ended December 31,   2021   2020  ($ in thousands, except per share amounts)         Net revenue $ 285,087 $ 215,791  Operating earnings   81,788   54,841  Net gains (losses)   142,623   (1,313 )Net earnings   190,740   46,068            EBITDA(1) $ 107,639 $ 77,702  Adjusted cash flow from operations(1)   84,792   63,050            Attributable to shareholders:    Net earnings $ 184,239 $ 42,358  EBITDA(1)   96,700   70,325  Adjusted cash flow from operations (1)   75,332   56,773  Per share, diluted:    Net earnings $ 6.87 $ 1.57  EBITDA(1)   3.61   2.60  Adjusted cash flow from operations (1)   2.81   2.10                 As...

Continue reading

Dorchester Minerals, L.P. Announces 2021 Results

DALLAS, Texas, Feb. 24, 2022 (GLOBE NEWSWIRE) — Dorchester Minerals, L.P. (the “Partnership”) (NASDAQ-DMLP) announced today the Partnership’s net income for the year ended December 31, 2021 of $70,174,000 or $1.94 per common unit. A comparison of the Partnership’s consolidated results for the twelve month periods ended December 31, 2021 and 2020 are set forth below:  Twelve Months Ended  December 31,   2021    2020Operating Revenues $ 93,423,000   $ 46,928,000 Net Income $   70,174,000   $   21,867,000 Net Income Per Common Unit $ 1.94   $ 0.61 The Partnership’s independent engineering consultant estimated its total proved oil and natural gas reserves to be 92.9 billion cubic feet of natural gas equivalents (bcfe) as of December 31, 2021. Approximately 17% of these reserves are attributable to the Partnership’s...

Continue reading

Bel Reports Fourth Quarter and Full Year 2021 Results

Impressive Top Line Growth with Solid Q4 Margin Improvement JERSEY CITY, N.J., Feb. 24, 2022 (GLOBE NEWSWIRE) — Bel Fuse Inc. (Nasdaq: BELFA and BELFB) today announced preliminary financial results for the fourth quarter and full year of 2021. Fourth Quarter 2021 HighlightsNet sales of $147.1 million, up 26.7% from Q4-20 Gross profit margin of 26.7%, up from 25.3% in Q4-20 Net earnings of $8.0 million versus $3.6 million in Q4-20 Adjusted EBITDA of $15.3 million, representing an increase of 96% compared to Q4-20Full Year 2021 HighlightsNet sales of $543.5 million, up 16.7% from 2020 Gross profit margin of 24.7%, down from 25.7% in 2020 Net earnings of $24.8 million versus $12.8 million in 2020 Adjusted EBITDA of $42.8 million, an improvement of 33% compared to 2020 Ended year with backlog of orders of $468 million, an increase...

Continue reading

VivoPower International PLC Reports Financial Results for the Six Months Ended December 31, 2021

Key strategic initiatives executed upon despite COVID-19 disruptions Revenue, GP and EBITDA decline due to strict prolonged COVID-19 lockdowns in key markets, especially Australia Definitive distribution partnerships for Tembo e-LV kits executed with GHH and Bodiz Full ownership of US solar portfolio secured, rebranded to Caret and launched cryptomining venture, Caret Decimal   LONDON, Feb. 24, 2022 (GLOBE NEWSWIRE) — VivoPower International PLC (NASDAQ: VVPR) (“VivoPower”, the “Company”) today announced its half year results for the six months ended December 31, 2021. Highlights for the half year ended December 31, 2021:Group revenue declined 11% to $18.9 million due to strict COVID-19 lockdowns affecting projects and deliveries. Group gross profit down 85% year on year to $0.5 million as a result, with group gross profit margin...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.